GENCURIX
Droplex - Genetic Testing Based on Digital PCR Platform
FromGENCURIX
These tests detect DNA mutations by analyzing certain genes extracted from the patient`s blood and tumor samples based on ddPCR platform which is optimized for companion diagnostics. They select patients who benefit the effectiveness of cancer treatment.
Most popular related searches
liquid biopsy sample
blood sampling
tumor samples
liquid biopsy
biopsy sampling
biopsy sample
cancer treatment
biopsy
patient blood
patient selection
Compared to traditional biopsy for gene mutation detection, blood samples require more sensitive testing because of their low DNA extraction. Digital PCR technology, ddPCR*, is a advanced platform specialized in liquid biopsy samples because it can detect mutations accurately even with a small amount of DNA.
